Publications - Page 52 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP)
Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems

Jevnikar M, Montani D, Savale L, Seferian A, Jutant EM, Boucly A, Preda M, Weatherald J, Bulifon S, Parent F, Brenot P, Fadel E, Sitbon O, Simonneau G, Humbert M, Jaïs X.

Eur Respir J. 2021 Jan 21;57(1):2002208. Doi: 10.1183/13993003.02208-2020.
Hypertension pulmonaire (HTP)
Sleep-related breathing disorders and pulmonary hypertension

Adir Y, Humbert M, Chaouat A.

Eur Respir J. 2021 Jan 5;57(1):2002258. Doi: 10.1183/13993003.02258-2020.
Hypertension pulmonaire (HTP)
Riociguat treatment in patients with pulmonary arterial hypertension : Final safety data from the EXPERT registry

Hoeper MM, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberà JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Ghofrani HA; Collaborators list.

Respir Med. 2020 Dec 3;177:106241. Doi: 10.1016/j.rmed.2020.106241.
Maladies pulmonaires chroniques kystiques (LAM/MKPM)
COVID-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mTOR inhibition.

Baldi BG, Radzikowska E, Cottin V, Dilling DF, Ataya A, Ribeiro Carvalho CR, Harari S, Koslow M, Grutters JC, Inoue Y, Gupta N, Johnson SR.

Chest. 2021 Dec 20:S0012-3692(21)05166-7.
Maladies pulmonaires chroniques kystiques (LAM/MKPM)
Tuberous sclerosis complex for the pulmonologist

Rebaine Y, Nasser M, Girerd B, Leroux C, Cottin V.

Eur Respir Rev. 2021 Aug 3;30(161):200348. Doi: 10.1183/16000617.0348-2020.
Maladies pulmonaires chroniques kystiques (LAM/MKPM)
Combined pulmonary fibrosis and emphysema in alpha-1-antitrypsin deficiency

Le Beller A, Nasser M, Traclet J, Blanchet-Legens AS, Kannengiesser C, Mornex JF, Cottin V.

Respir Med Res. 2021 May;79:100819. Doi: 10.1016/j.resmer.2021.100819.
Maladies pulmonaires chroniques kystiques (LAM/MKPM)
[Erratum to “Screening for alpha1-antitrypsin deficiency using dried blood spot: Assessment of the first 20 months” [Rev. Mal. Respir. 37 (2020) 633-43]]

Chapuis Cellier C, Narjoz C, Zerimech F, Odou MF, Joly P, Lombard C, Mornex JF, Balduyck M.

Rev Mal Respir. 2021 Jan;38(1):125-126. Doi: 10.1016/j.rmr.2020.11.011.
Maladies pulmonaires chroniques liées à l’environnement
Nebulised liposomal-amphotericin-B as maintenance therapy in ABPA: a randomised, multicentre, trial

Godet C, Couturaud F, Marchand-Adam S, Pison C, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Bourdin A, Chenivesse C, Dominique S, Bassinet L, Murris-Espin M, Rivière F, Garcia G, Caillaud D, Blanc FX, Goupil F, Bergeron A, Gondouin A, Frat JP, Flament T, Camara B, Priou P, Brun AL, Laurent F, Ragot S, Cadranel J; NebuLamB* study group and GREPI network.

Eur Respir J. 2021 Nov 11:2102218.
Maladies pulmonaires chroniques liées à l’environnement
Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronchopulmonary Aspergillosis

Lukaszewicz R, Mahay G, Boyer O, Martinet J.

Allergy. 2021 Jul 12. Doi: 10.1111/all.15001.
Maladies pulmonaires chroniques liées à l’environnement
[Allergic Broncho-Pulmonary Aspergillosis (ABPA) in cystic fibrosis: Mechanisms, diagnosis and therapeutic options]

Bui S, Dournes G, Fayon M, Bouchet S, Burgel PR, Macey J, Murris M, Delhaes L.

Rev Mal Respir. 2021 May;38(5):466-476. Doi: 10.1016/j.rmr.2021.04.004.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems

Sleep-related breathing disorders and pulmonary hypertension

Riociguat treatment in patients with pulmonary arterial hypertension : Final safety data from the EXPERT registry

COVID-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mTOR inhibition.

Tuberous sclerosis complex for the pulmonologist

Combined pulmonary fibrosis and emphysema in alpha-1-antitrypsin deficiency

[Erratum to “Screening for alpha1-antitrypsin deficiency using dried blood spot: Assessment of the first 20 months” [Rev. Mal. Respir. 37 (2020) 633-43]]

Nebulised liposomal-amphotericin-B as maintenance therapy in ABPA: a randomised, multicentre, trial

Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronchopulmonary Aspergillosis

[Allergic Broncho-Pulmonary Aspergillosis (ABPA) in cystic fibrosis: Mechanisms, diagnosis and therapeutic options]